Status:
COMPLETED
Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)
Lead Sponsor:
Stony Brook University
Collaborating Sponsors:
Teva Pharmaceuticals USA
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
This study focuses on stress, cognition, mood and fatigue and its effect on medication compliance. Medication compliance is measured by the weight of discarded needles. The investigators will be admin...
Eligibility Criteria
Inclusion
- Patients with either definite MS according to the revised McDonald criteria (Polman 2005) or patients with CIS (defined as an initial MS relapse with objective documentation and 2 or more lesions within the CNS of which at least one must involve the brain)
- Patients on GA therapy for at least 6 months
- Age 18 - 70
Exclusion
- Unwilling to comply with study procedures
- Use of other DMT in conjunction with GA
- Unable to provide informed consent.
- Current (past 30 days) substance abuse
- Newly initiated (past 30 days) psychiatry treatment
- Enrolled in another program of meditation in the past six months.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT01419301
Start Date
May 1 2011
End Date
November 1 2014
Last Update
November 20 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University
Stony Brook, New York, United States, 11786-8121